系统综述与Meta分析:艰难梭菌感染对炎症性肠病短期和长期结肠切除术风险的影响
该Meta分析纳入12项观察性研究,比较有与无艰难梭菌感染的炎症性肠病患者结肠切除术风险。结果显示艰难梭菌感染未增加短期结肠切除术风险(OR 1.35,95%CI 0.68-2.67),但增加长期风险(OR 2.23,95%CI 1.18-4.21)。
要点
- 艰难梭菌感染未增加炎症性肠病短期结肠切除术风险(OR 1.35,95%CI 0.68-2.67)
- 艰难梭菌感染增加炎症性肠病长期结肠切除术风险(OR 2.23,95%CI 1.18-4.21)
- 溃疡性结肠炎亚组长期风险更高(OR 2.96,95%CI 1.19-7.34)
核心结论
- 基于12项至少中等质量的观察性研究,艰难梭菌感染似乎增加炎症性肠病长期而非短期的结肠切除术风险。
研究设计与样本
- 系统综述与Meta分析,检索多个数据库的观察性研究,纳入12项研究,包括35057例有艰难梭菌感染的炎症性肠病患者和929259例无艰难梭菌感染者。
- 采用广义逆方差随机效应模型计算加权汇总估计值。
主要发现
- 艰难梭菌感染未增加炎症性肠病总体短期结肠切除术风险(10项研究)(OR 1.35;95%CI 0.68-2.67)。
- 艰难梭菌感染未增加溃疡性结肠炎患者短期结肠切除术风险(9项研究)(OR 1.20;95%CI 0.39-3.76)。
- 艰难梭菌感染与炎症性肠病总体长期结肠切除术风险升高相关(5项研究)(OR 2.23;95%CI 1.18-4.21)。
- 艰难梭菌感染与溃疡性结肠炎患者长期结肠切除术风险升高相关(4项研究)(OR 2.96;95%CI 1.19-7.34)。
- 按招募时期、住院状态和地理位置分层的亚组结果稳定。
关键数值与推荐
- 短期随访定义为3个月,长期随访定义为至少1年。
临床怎么用
- 原文未据此给出推荐。
局限性
- 结果在比较炎症性肠病严重程度和抗微生物治疗类型方面的能力有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Clostridium difficile infection (CDI) is associated with increased mortality in inflammatory bowel disease (IBD), but the risk of colectomy is variable and has not been adequately studied. AIM: To perform a systematic review and meta-analysis to assess the impact of CDI on colectomy risk in IBD. METHODS: Multiple databases were searched systematically for observational studies reporting colectomy risk in IBD, stratified by the presence of CDI, and the duration of follow-up (short term 3 months, and long term at least 1 year). Weighted summary estimates were calculated using generalised inverse variance with random-effects model. Study quality was assessed using the Newcastle-Ottawa scale. RESULTS: Twelve observational studies were identified and included 35 057 IBD patients with CDI, and 929 259 without CDI. CDI did not increase the short-term colectomy risk in IBD patients overall (10 studies) (OR: 1.35; 95% CI: 0.68-2.67), or in patients with ulcerative colitis (nine studies) (OR: 1.20; 95% CI: 0.39-3.76). In contrast, CDI was associated with higher long-term colectomy risk in patients with IBD overall (five studies) (OR: 2.23; 95% CI: 1.18-4.21), and in patients with ulcerative colitis (four studies) (OR: 2.96; 95% CI: 1.19-7.34). The results were stable in subgroups stratified by recruitment period, hospitalisation status and geographical location. All studies were at least of moderate quality. The results were limited in the ability to compare IBD severity and the type of anti-microbial therapy. CONCLUSION: Based on 12 observational studies with at least moderate quality, Clostridium difficile infection appears to increase colectomy risk in IBD in the long- but not short- term.
引用
- Law CC, Tariq R, Khanna S, et al. Systematic review with meta-analysis: the impact of Clostridium difficile infection on the short- and long-term risks of colectomy in inflammatory bowel disease. Aliment Pharmacol Ther. 2017. PMID: 28206678. doi:10.1111/apt.13972
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。